75F40123F19016↗

Name: 75F40123F19016: Business Process Improvement/Strategic Planning
Creator: SpendQuery

BUSINESS PROCESS IMPROVEMENT/STRATEGIC PLANNING

Bpa Call · Food and Drug Administration · to Booz Allen Hamilton Inc (UEI JCBMLGPE6Z71) · data as of 2026-09-30

Obligated to date$960.7K3 actions

Current value$960.7Kwith options exercised

Period2023-02-10 → 2023-10-31current end date

What it is

Product or service: Support- Professional: Program Management/Support (PSC R408)
Industry: Administrative Management and General Management Consulting Services (NAICS 541611)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition
Pricing: Labor hours
How it was bought: Blanket purchase agreement (BPA) · under 75F40122A00008
Where the work is: Montgomery, MD · district MD-08
Funding law: COVID-19 laws

Obligations by fiscal year

FY2023$961.1K

FY2024-$426

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

3 actions since 2023-02-10. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2024-05-17	P00002	Close-out	-$426	BUSINESS PROCESS IMPROVEMENT/STRATEGIC PLANNING
2023-09-06	P00001	Option exercised	$0	BUSINESS PROCESS IMPROVEMENT/STRATEGIC PLANNING
2023-02-10	0		$961.1K	BUSINESS PROCESS IMPROVEMENT/STRATEGIC PLANNING

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗